Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biofrontera (BFRI) Net Margin: 2020-2025

Historic Net Margin for Biofrontera (BFRI) over the last 5 years, with Sep 2025 value amounting to -95.15%.

  • Biofrontera's Net Margin fell 3224.00% to -95.15% in Q3 2025 from the same period last year, while for Sep 2025 it was -47.28%, marking a year-over-year decrease of 1098.00%. This contributed to the annual value of -47.58% for FY2024, which is 1150.00% up from last year.
  • Latest data reveals that Biofrontera reported Net Margin of -95.15% as of Q3 2025, which was down 61.38% from -58.96% recorded in Q2 2025.
  • Biofrontera's Net Margin's 5-year high stood at 57.03% during Q1 2022, with a 5-year trough of -369.45% in Q3 2021.
  • In the last 3 years, Biofrontera's Net Margin had a median value of -62.91% in 2024 and averaged -64.01%.
  • Per our database at Business Quant, Biofrontera's Net Margin tumbled by 27,766bps in 2021 and then spiked by 31,008bps in 2022.
  • Quarterly analysis of 5 years shows Biofrontera's Net Margin stood at -158.21% in 2021, then skyrocketed by 13,076bps to -27.45% in 2022, then spiked by 6,073bps to 33.28% in 2023, then slumped by 4,439bps to -11.12% in 2024, then slumped by 3,224bps to -95.15% in 2025.
  • Its last three reported values are -95.15% in Q3 2025, -58.96% for Q2 2025, and -48.94% during Q1 2025.